Clinical Trial of an Automated Smartphone Based Smoking Cessation Treatment
Smart-T2
Pilot Randomized Clinical Trial of an Automated Smartphone Based Smoking Cessation Treatment
1 other identifier
interventional
98
1 country
1
Brief Summary
The primary long-term objective of this research is to reduce smoking relapse through the use of automated mobile smoking cessation interventions that tailor content (e.g., treatment messages/materials) in real-time based upon currently present symptoms. The primary short-term objective of this pilot study is to determine the initial utility of a novel smartphone based smoking cessation intervention compared with standard in-person smoking cessation clinic care and the free National Cancer Institute (NCI) QuitGuide smoking cessation application. The current pilot study is a 3 armed randomized clinical trial that aims to determine the initial utility of a novel smartphone based smoking cessation intervention compared with standard in-person smoking cessation clinic care and the free NCI QuitGuide smoking cessation application.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 7, 2016
CompletedFirst Posted
Study publicly available on registry
October 12, 2016
CompletedStudy Start
First participant enrolled
May 30, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2018
CompletedJune 20, 2019
June 1, 2019
1.4 years
October 7, 2016
June 18, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Biochemically-verified smoking cessation
Biochemically-verified smoking cessation will be verified if the participants have a CO level of \< 10 on the quit day and \< 6 ppm at all subsequent post-quit visits
12 weeks post-quit
Study Arms (3)
Treatment as Usual
ACTIVE COMPARATORBehavioral: Treatment as Usual (TAU) is the Tobacco Treatment Research Program (TTRP) which offers all components of an intensive tobacco treatment intervention including: 1) initial assessment of willingness to participate, 2) the use of multiple types of clinicians, 3) at least 4 treatment sessions, in an individual- or group-counseling format, that are greater than 10 minutes in duration, 4) counseling that includes problem-solving, skills training, and social support components, and 5) and the opportunity to use effective medications to aid in tobacco cessation.
NCI QuitGuide
ACTIVE COMPARATORBehavioral: The National Cancer Institute's (NCI's) QuitGuide app is a free smartphone app that is available through the Smokefree.gov website. Participants can track cravings, smoking triggers, and motivations for quitting. Participants who are randomly assigned to the QuitGuide app group will receive a smartphone that is preloaded with the QuitGuide app and a quit date scheduled for 1 week after the baseline visit.
Smart-T
EXPERIMENTALBehavioral: The Smart-Treatment (Smart-T) phone based smoking cessation intervention has multiple components (e.g., an on-demand "Quit Tips" function, an on-demand "Medications" function/button that offers information about nicotine replacement therapy (NRT), button available 24/7 that offers general smoking cessation advice, daily treatment messages, and an algorithm that uses participant's EMA responses to assess risk of lapse and automatically push relevant messages to help them avoid smoking).
Interventions
Tobacco Treatment Research Program (TTRP) or Treatment as Usual (TAU)
Eligibility Criteria
You may qualify if:
- earn a score ≥ 4 on the Short REALM indicating \> 6th grade English literacy level,
- are willing to quit smoking 7 days from their first visit,
- are ≥ 18 years of age,
- have an expired carbon monoxide (CO) level \> 7 ppm suggestive of current smoking,
- are currently smoking ≥ 5 cigarettes per day,
- are willing and able to attend 4 assessment sessions (i.e., baseline, quit day \[1 week after baseline\], 4 weeks post-quit, 12 weeks post-quit), and
- have no contraindications for over the counter NRT (i.e., individuals with uncontrolled blood pressure, history of myocardial infarction within the past two weeks, or current pregnancy, breastfeeding, or plans to become pregnant during the study period will be excluded).
You may not qualify if:
- cannot read, speak, and understand English
- are \< 18 years of age
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Oklahoma Health Sciences Center - OTRC
Oklahoma City, Oklahoma, 73104, United States
Related Publications (3)
Benson L, Chen M, De La Torre I, Hebert ET, Alexander A, Ra CK, Kendzor DE, Businelle MS. Associations between morning affect and later-day smoking urges and behavior. Psychol Addict Behav. 2024 May;38(3):277-295. doi: 10.1037/adb0000970. Epub 2023 Dec 14.
PMID: 38095939DERIVEDBenson L, Ra CK, Hebert ET, Kendzor DE, Oliver JA, Frank-Pearce SG, Neil JM, Businelle MS. Quit Stage and Intervention Type Differences in the Momentary Within-Person Association Between Negative Affect and Smoking Urges. Front Digit Health. 2022 Mar 29;4:864003. doi: 10.3389/fdgth.2022.864003. eCollection 2022.
PMID: 35425934DERIVEDHebert ET, Ra CK, Alexander AC, Helt A, Moisiuc R, Kendzor DE, Vidrine DJ, Funk-Lawler RK, Businelle MS. A Mobile Just-in-Time Adaptive Intervention for Smoking Cessation: Pilot Randomized Controlled Trial. J Med Internet Res. 2020 Mar 9;22(3):e16907. doi: 10.2196/16907.
PMID: 32149716DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michael Businelle, PhD
University of Oklahoma
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 7, 2016
First Posted
October 12, 2016
Study Start
May 30, 2017
Primary Completion
November 1, 2018
Study Completion
November 1, 2018
Last Updated
June 20, 2019
Record last verified: 2019-06
Data Sharing
- IPD Sharing
- Will not share